References
- Baral, S. D., Poteat, T., Stromdahl, S., Wirtz, A. L., Guadamuz, T. E., & Beyrer, C. (2013). Worldwide burden of HIV in transgender women: A systematic review and meta-analysis. The Lancet Infectious Diseases, 13(3), 214–222. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23260128. doi: 10.1016/S1473-3099(12)70315-8
- Carlo Hojilla, J., Koester, K. A., Cohen, S. E., Buchbinder, S., Ladzekpo, D., Matheson, T., & Liu, A. Y. (2016). Sexual behavior, risk compensation, and HIV prevention strategies Among participants in the San Francisco PrEP demonstration project: A qualitative analysis of counseling notes. AIDS and Behavior, 20(7), 1461–1469. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/25835463. doi: 10.1007/s10461-015-1055-5
- (CDC), C. f. D. C. a. P. (2018). Pre-exposure prophylaxis (PrEP). Retrieved from https://www.cdc.gov/hiv/risk/prep/index.html
- Costa, A. B., da Rosa Filho, H. T., Pase, P. F., Fontanari, A. M. V., Catelan, R. F., Mueller, A., … Koller, S. H. (2018). Healthcare needs of and access barriers for Brazilian transgender and gender diverse people. Journal of Immigrant and Minority Health, 20(1), 115–123. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27804013. doi: 10.1007/s10903-016-0527-7
- Deutsch, M. B., Glidden, D. V., Sevelius, J., Keatley, J., McMahan, V., Guanira, J., … iPrEx, i. (2015). Hiv pre-exposure prophylaxis in transgender women: A subgroup analysis of the iPrEx trial. The Lancet HIV, 2(12), e512–519. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26614965. doi: 10.1016/S2352-3018(15)00206-4
- Grant, J. M., Mottet, L. A., Tanis, J., Herman, J. L., Harrison, J., & Keisling, M. (2010). National transgender discrimination survey report on health and health care. Retrieved from http://transequality.org/PDFs/NTDSReportonHealth_final.pdf
- Grinsztejn, B., Jalil, E. M., Monteiro, L., Velasque, L., Moreira, R. I., Garcia, A. C., … Transcender Study, T. (2017). Unveiling of HIV dynamics among transgender women: A respondent-driven sampling study in Rio de Janeiro, Brazil. The Lancet HIV, 4(4), e169–e176. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28188030. doi: 10.1016/S2352-3018(17)30015-2
- Grov, C., Whitfield, T. H., Rendina, H. J., Ventuneac, A., & Parsons, J. T. (2015). Willingness to take PrEP and potential for risk compensation among highly sexually active Gay and bisexual Men. AIDS and Behavior, 19(12), 2234–2244. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/25735243. doi: 10.1007/s10461-015-1030-1
- Hoagland, B., De Boni, R. B., Moreira, R. I., Madruga, J. V., Kallas, E. G., Goulart, S. P., … Pr, E. P. B. S. T. (2017). Awareness and willingness to use pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women in Brazil. AIDS and Behavior, 21(5), 1278–1287. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27531461. doi: 10.1007/s10461-016-1516-5
- Hoagland, B., Moreira, R. I., De Boni, R. B., Kallas, E. G., Madruga, J. V., Vasconcelos, R., … PrEP Brasil Study TeamClinical Trial Number. (2017). High pre-exposure prophylaxis uptake and early adherence among men who have sex with men and transgender women at risk for HIV infection: The PrEP Brasil demonstration project. Journal of the International AIDS Society, 20(1), 21472. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/28418232. doi: 10.7448/IAS.20.1.21472
- Jalil, E. (2016). HIV treatment cascade among transgender women: Population estimates from Rio de Janeiro, Brazil. Paper presented at the HIV Research for Prevention 2016: AIDS Vaccine, Microbicide and ARV-based Prevention Science (HIVR4P), Chicago, IL (USA).
- Krippendorf, K. (1980). Content analysis: An introduction to its methodology. Beverly Hills, CA: Sage.
- Kulick, D. (1998). Travestis. Chicago, IL: University of Chicago Press.
- Marcus, J. L., Glidden, D. V., Mayer, K. H., Liu, A. Y., Buchbinder, S. P., Amico, K. R., … Grant, R. M. (2013). No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One, 8(12), e81997. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/24367497. doi: 10.1371/journal.pone.0081997
- Mayer, K. H., Maloney, K. M., Levine, K., King, D., Grasso, C., Krakower, D. S., … Boswell, S. L. (2017). Sociodemographic and clinical factors associated with increasing bacterial sexually transmitted infection diagnoses in men who have sex with men accessing care at a Boston community health center (2005–2015). Open Forum Infectious Diseases, 4(4), 367. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/29181421. doi: 10.1093/ofid/ofx214
- Newcomb, M. E., Moran, K., Feinstein, B. A., Forscher, E., & Mustanski, B. (2018). Pre-exposure prophylaxis (PrEP) use and condomless anal sex. JAIDS Journal of Acquired Immune Deficiency Syndromes, 77(4), 358–364. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/29210834. doi: 10.1097/QAI.0000000000001604
- Paim, J., Travassos, C., Almeida, C., Bahia, L., & Macinko, J. (2011). The Brazilian health system: History, advances, and challenges. The Lancet, 377(9779), 1778–1797. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/21561655. doi: 10.1016/S0140-6736(11)60054-8
- Peterson, L., Taylor, D., Roddy, R., Belai, G., Phillips, P., Nanda, K., … Cates, W. (2007). Tenofovir disoproxil fumarate for prevention of HIV infection in women: A phase 2, double-blind, randomized, placebo-controlled trial. PLoS Clinical Trials, 2(5), e27. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17525796. doi: 10.1371/journal.pctr.0020027
- Raifman, J. R., Flynn, C., & German, D. (2016). Healthcare provider contact and pre-exposure prophylaxis in Baltimore men who have sex with men. American Journal of Preventive Medicine. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27662698. doi: 10.1016/j.amepre.2016.07.031
- Rapues, J., Wilson, E. C., Packer, T., Colfax, G. N., & Raymond, H. F. (2013). Correlates of HIV infection among transfemales, San Francisco, 2010: Results from a respondent-driven sampling study. American Journal of Public Health, 103(8), 1485–1492. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23763398. doi: 10.2105/AJPH.2012.301109
- Rocon, P. C., Rodrigues, A., Zamboni, J., & Pedrini, M. D. (2016). Dificuldades vividas por pessoas trans no acesso ao sistema Único de saúde. Ciencia & Saude Coletiva, 21(8), 2517–2526. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27557024. doi: 10.1590/1413-81232015218.14362015
- Saggese, G., Veras, M. A., Puccinelli, B., Barbosa, B. C., Teixeira, F., Barros, D., … Group, M. S. (2016). Vulnerabilities, human rights and health issues among transgender persons: A qualitative approach with in-depth interviews and workshops in São Paulo, Brazil. Paper presented at the International AIDS Society Annual Meeting, Durban, South Africa. http://programme.aids2016.org/Search/Search?search=Muriel.
- Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Global Public Health, 11(7-8), 1060–1075. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26963756. doi: 10.1080/17441692.2016.1154085
- Silva-Santisteban, A., Eng, S., de la Iglesia, G., Falistocco, C., & Mazin, R. (2016). HIV prevention among transgender women in Latin America: Implementation, gaps and challenges. Journal of The International Aids Society, 19(3 Suppl. 2), 20799. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/27431470. doi: 10.7448/IAS.19.3.20799
- UNAIDS. (2014). The GAP report. http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/unaidspublication/2014/UNAIDS_Gap_report_en.pdf.
- US Public Health Service. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States – 2014 clinical practice guideline. Washington, DC.
- Veras, M. A., Cezaretto, A., Deus, L. F., Gomez, J. L., Barros, D., Saggese, G., … Group, M. S. (2016). Trans incarceration experiences, cycle of violence and increased risk of HIV infection: Results from Muriel Project, Sao Paulo, Brazil. Paper presented at the Annual meeting of the International AIDS society, Durban, South Africa.
- Wilson, E. C., Jin, H., Liu, A., & Raymond, H. F. (2015). Knowledge, indications and willingness to take Pre-exposure prophylaxis among transwomen in San Francisco, 2013. PLoS ONE, 10(6), e0128971. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26039511. doi: 10.1371/journal.pone.0128971
- Wilson, E., Chen, Y. H., Pomart, W. A., & Arayasirikul, S. (2016). Awareness, interest, and HIV pre-exposure prophylaxis candidacy among young transwomen. AIDS Patient Care and STDs, 30(4), 147–150. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/26982698. doi: 10.1089/apc.2015.0266